Skip to content

Abortion Case Could Limit Accessibility of Medication and Harm The Future Of Reproductive Health

People in this story

By: Matt Hrkac

A new Supreme Court case U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine puts the expansion of mifepristone at risk, leading to less access to abortion and reproductive care. The FDA has added and changed restrictions and accessibility of Mifepristone over the past few years. Click the link below to read the full article and learn about the decisions made for the abortion pill.

Read the full story here!

This article was written by Wendy Parmet, affiliated faculty in WGSS. Wendy is also a co-PI on the Reproductive Justice Research Collaborative (RJRC) grant.

More Stories

Abortion pills become accessible at pharmacy chains CVS and Walgreens in select locations.


Northeastern begins Black History Month with the Third annual bell hooks symposium, ‘Black Feminist Worldmaking’


New I.V.F Supreme Court of Alabama ruling shows only the beginning of the fight over fertility treatment.

All Stories